Stockscreener 앱 받기
8.54
5.43%
-0.49
Scisparc Ltd 주식(SPRC)의 최신 뉴스
Neurothera Labs Announces Continuance into Ontario - TheNewswire
SciSparc (NASDAQ: SPRC) 20-F shows widening losses and going concern risk - Stock Titan
SPRC Stock Price, Quote & Chart | SCISPARC LTD (NASDAQ:SPRC) - ChartMill
SciSparc stock rallies after AutoMax files motion on pending merger - MSN
SPRC Technical Analysis | Trend, Signals & Chart Patterns | SCISPARC LTD (NASDAQ:SPRC) - ChartMill
Neurothera Labs Engages bullVestor for Investor Relations Activities - TheNewswire
SciSparc receives Nasdaq notice over stockholders’ equity shortfall - MSN
SPRC Stock Pops On Volatile Run As Traders Circle - timothysykes.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
SciSparc (SPRC) Stock Volume Ratio (Slips) 2026-04-20RSI Overbought Stocks - Cổng thông tin điện tử tỉnh Lào Cai
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Amnon Ben Shay Net Worth (2026) - GuruFocus
Adi Zuloff Shani Net Worth (2026) - GuruFocus
Lior Vider Net Worth (2026) - GuruFocus
Is SciSparc (SPRC) Stock better than industry peers | Price at $3.02, Down 3.95%Open Stock Signal Network - UBND thành phố Hải Phòng
Block Trades: Can SciSparc Ltd scale operations efficientlyQuarterly Portfolio Summary & Breakout Confirmation Alerts - baoquankhu1.vn
Institution Moves: Can SciSparc Ltd outperform in the next rallyEntry Point & Community Verified Swing Trade Signals - baoquankhu1.vn
Market Trends: What makes SciSparc Ltd stock attractive todayOptions Play & Safe Entry Point Alerts - baoquankhu1.vn
MACD Signal: Is SciSparc Ltd impacted by rising ratesWeekly Risk Summary & Real-Time Buy Zone Alerts - baoquankhu1.vn
Institution Moves: Is SciSparc Ltd impacted by rising rates2026 Drop Watch & Breakout Confirmation Alerts - baoquankhu1.vn
Buyback Watch: Can SciSparc Ltd outperform in the next rallyWeekly Trade Analysis & Smart Allocation Stock Tips - baoquankhu1.vn
SPRC Should I Buy - Intellectia AI
Is SciSparc (SPRC) Stock sensitive to interest rates | Price at $3.54, Down 3.28%Crowd Entry Signals - Xã Châu Thành
SPRC Stock Analysis: SciSparc Ltd. Ordinary Shares biotech 0.41% dip at 3.66 view - UBND thành phố Hải Phòng
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Whale Trades: How correlated is SciSparc Ltd to the S P5002026 Macro Impact & Entry Point Confirmation Alerts - baoquankhu1.vn
SciSparc (SPRC) director Dayan Alon reports 3,651-share ownership stake - Stock Titan
SPRC SEC FilingsScisparc 10-K, 10-Q, 8-K Forms - Stock Titan
SciSparc (SPRC) director discloses shares, options and RSU awards - stocktitan.net
SciSparc (SPRC) director reports initial share and option holdings - Stock Titan
SciSparc (SPRC) director Revach Moshe discloses initial share and RSU holdings - Stock Titan
SciSparc (SPRC) CEO Adler Oz details share, option and RSU holdings - Stock Titan
SciSparc (SPRC) director Weiss Amitay details equity holdings - Stock Titan
SciSparc (SPRC) director Vider Lior details shares, options and RSUs - Stock Titan
SciSparc (SPRC) CTO details 5,528 Ordinary Shares and option holdings on Form 3 - Stock Titan
SciSparc (SPRC) director reports 3,651-share stake and RSU grants - Stock Titan
Sentiment Watch: Can SciSparc Ltd stock outperform in a bear marketRecession Risk & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Buyout Rumor: Is SciSparc Ltd impacted by rising ratesMarket Performance Report & Low Drawdown Investment Ideas - baoquankhu1.vn
SciSparc subsidiary files patent for depression treatment By Investing.com - Investing.com India
[SCHEDULE 13G] SciSparc Ltd. Passive Investment Disclosure (>5%) - Stock Titan
SciSparc’s NeuroThera-Backed Collaboration Spurs New Depression Therapy Patent Filing - TipRanks
Eli Zamir reports ≤5% stake in SciSparc (NASDAQ: SPRC) - Stock Titan
SciSparc (NASDAQ: SPRC) collaboration advances MEAI-PEA depression patent bid - Stock Titan
SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy - Bitget
SciSparc subsidiary files patent for depression treatment - Investing.com
SciSparc Ltd. Reports NeuroThera Labs' Patent Application for Innovative Depression Treatment Combining MEAI and PEA - quiverquant.com
SciSparc Subsidiary NeuroThera to Take Majority Stake in Quantum Trials Firm CliniQuantum - TipRanks
SciSparc (Nasdaq: SPRC) unit to acquire 54% of CliniQuantum and lose NeuroThera control - Stock Titan
SciSparc’s Neurothera Labs announces publication of international patent - TipRanks
SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease - Bitget
SciSparc Ltd. Advances Collaboration with NeuroThera Labs Inc. and Clearmind Medicine Inc. for Novel Combination Therapy Targeting Obesity and MASLD. - Quiver Quantitative
SciSparc: NeuroThera Labs Announces Publication of - GlobeNewswire
SciSparc: $9.46 Million NeuroThera Deal To Acquire Majority Stake In Quantum Clinical Trials Firm CliniQuantum - Pulse 2.0
2.85%
자본화:
|
볼륨(24시간):